News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,276 Results
Type
Article (29250)
Company Profile (97)
Press Release (460929)
Multimedia
Podcasts (39)
Webinars (7)
Section
Business (148578)
Career Advice (1708)
Deals (25315)
Drug Delivery (66)
Drug Development (63531)
Employer Resources (117)
FDA (12806)
Job Trends (10127)
News (251777)
Policy (21300)
Tag
Academia (1841)
Accelerated approval (3)
Adcomms (16)
Allergies (64)
Alliances (32013)
ALS (76)
Alzheimer's disease (1004)
Antibody-drug conjugate (ADC) (115)
Approvals (12845)
Artificial intelligence (181)
Autoimmune disease (20)
Automation (15)
Bankruptcy (262)
Best Places to Work (8117)
BIOSECURE Act (15)
Biosimilars (92)
Biotechnology (82)
Bladder cancer (54)
Brain cancer (23)
Breast cancer (218)
Cancer (1897)
Cardiovascular disease (147)
Career advice (1441)
Career pathing (26)
CAR-T (133)
Cell therapy (346)
Cervical cancer (18)
Clinical research (52916)
Collaboration (603)
Compensation (441)
Complete response letters (9)
COVID-19 (1901)
CRISPR (39)
C-suite (202)
Cystic fibrosis (88)
Data (1915)
Decentralized trials (1)
Denatured (2)
Depression (40)
Diabetes (179)
Diagnostics (4571)
Digital health (12)
Diversity (3)
Diversity, equity & inclusion (29)
Drug discovery (88)
Drug pricing (81)
Drug shortages (7)
Duchenne muscular dystrophy (84)
Earnings (70466)
Editorial (35)
Employer branding (17)
Employer resources (105)
Events (74970)
Executive appointments (570)
FDA (13937)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (587)
Gene editing (92)
Generative AI (13)
Gene therapy (268)
GLP-1 (544)
Government (2733)
Grass and pollen (3)
Guidances (154)
Healthcare (13270)
Huntington's disease (20)
IgA nephropathy (29)
Immunology and inflammation (108)
Indications (25)
Infectious disease (2011)
Inflammatory bowel disease (118)
Inflation Reduction Act (9)
Influenza (35)
Intellectual property (51)
Interviews (320)
IPO (12744)
IRA (34)
Job creations (2313)
Job search strategy (1188)
Kidney cancer (9)
Labor market (34)
Layoffs (367)
Leadership (17)
Legal (4626)
Liver cancer (63)
Lung cancer (275)
Lymphoma (138)
Machine learning (5)
Management (37)
Manufacturing (209)
MASH (66)
Medical device (9820)
Medtech (9823)
Mergers & acquisitions (12922)
Metabolic disorders (500)
Multiple sclerosis (66)
NASH (18)
Neurodegenerative disease (80)
Neuropsychiatric disorders (21)
Neuroscience (1452)
NextGen: Class of 2025 (4371)
Non-profit (2794)
Now hiring (13)
Obesity (267)
Opinion (172)
Ovarian cancer (67)
Pain (76)
Pancreatic cancer (72)
Parkinson's disease (113)
Partnered (11)
Patents (133)
Patient recruitment (108)
Peanut (34)
People (39882)
Pharmaceutical (24)
Pharmacy benefit managers (5)
Phase I (17134)
Phase II (22732)
Phase III (17751)
Pipeline (1270)
Policy (102)
Postmarket research (1850)
Preclinical (5894)
Press Release (70)
Prostate cancer (82)
Psychedelics (21)
Radiopharmaceuticals (207)
Rare diseases (341)
Real estate (4026)
Recruiting (51)
Regulatory (15658)
Reports (29)
Research institute (1628)
Resumes & cover letters (278)
Rett syndrome (6)
RNA editing (5)
RSV (32)
Schizophrenia (71)
Series A (99)
Series B (81)
Service/supplier (4)
Sickle cell disease (45)
Special edition (17)
Spinal muscular atrophy (141)
Sponsored (17)
Startups (2598)
Stomach cancer (14)
Supply chain (39)
Tariffs (37)
The Weekly (36)
Vaccines (532)
Venture capitalists (22)
Weight loss (159)
Women's health (23)
Worklife (13)
Date
Today (201)
Last 7 days (787)
Last 30 days (2713)
Last 365 days (24124)
2025 (9336)
2024 (26420)
2023 (30462)
2022 (37923)
2021 (40374)
2020 (38084)
2019 (32415)
2018 (24598)
2017 (23612)
2016 (21902)
2015 (25999)
2014 (20103)
2013 (15955)
2012 (17169)
2011 (17788)
2010 (18371)
Location
Africa (584)
Alabama (36)
Alaska (7)
Arizona (134)
Arkansas (10)
Asia (29430)
Australia (4841)
California (4856)
Canada (1465)
China (433)
Colorado (185)
Connecticut (219)
Delaware (140)
Europe (63365)
Florida (634)
Georgia (150)
Idaho (36)
Illinois (375)
India (18)
Indiana (208)
Iowa (6)
Japan (148)
Kansas (70)
Kentucky (19)
Louisiana (9)
Maine (62)
Maryland (611)
Massachusetts (4099)
Michigan (156)
Minnesota (352)
Mississippi (2)
Missouri (57)
Montana (22)
Nebraska (20)
Nevada (44)
New Hampshire (36)
New Jersey (1361)
New Mexico (17)
New York (1270)
North Carolina (743)
North Dakota (7)
Northern California (2202)
Ohio (134)
Oklahoma (8)
Oregon (26)
Pennsylvania (956)
Puerto Rico (7)
Rhode Island (23)
South America (798)
South Carolina (20)
South Dakota (1)
Southern California (1837)
Tennessee (74)
Texas (666)
United States (17993)
Utah (134)
Virginia (101)
Washington D.C. (36)
Washington State (410)
West Virginia (2)
Wisconsin (41)
490,276 Results for "credit suisse first boston corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Scientific announces results for first quarter 2025
April 23, 2025
·
19 min read
Press Releases
Boston Scientific announces conference call discussing first quarter 2025 results
April 1, 2025
·
1 min read
Business
Boston Scientific Announces Results for First Quarter 2024
Boston Scientific Corporation generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period.
April 24, 2024
·
20 min read
Press Releases
Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update
May 14, 2025
·
9 min read
Press Releases
Redwire Corporation Reports First Quarter 2025 Financial Results
May 12, 2025
·
19 min read
Press Releases
Poxel Reports Consolidated Revenue for the First Quarter 2025 and Provides Corporate Update
May 13, 2025
·
10 min read
Press Releases
CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS
April 25, 2025
·
31 min read
Genetown
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2024, on Wednesday, April 24, 2024, at 8:00 a.m. ET.
April 1, 2024
·
1 min read
Press Releases
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
May 13, 2025
·
8 min read
Press Releases
STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
May 15, 2025
·
12 min read
1 of 49,028
Next
